NES and glioblastoma: Immunoreactivity for Nestin, which is a neuronal stem cell marker [3], was significantly higher in non-Ps and Ps perinecrotic lesions as compared to non-necrotic areas in GBM tissues (Additional file 2: Figure S2A).